PCRX vs AAPL: Which Stock is Better?
Side-by-side comparison of Pacira Biosciences Inc and Apple Inc in 2026
PCRX
Pacira Biosciences Inc
$23.86
AAPL
Apple Inc
$270.52
Key Metrics Comparison
| Metric | PCRX | AAPL | Winner |
|---|---|---|---|
| Market Cap | $1.03B | N/A | PCRX |
| P/E Ratio | 149.13 | 33.32 | AAPL |
| EPS (TTM) | $0.16 | $8.11 | AAPL |
| Revenue Growth | 0.1% | 0.2% | AAPL |
| Gross Margin | 63.2% | 47.3% | PCRX |
Analyze PCRX
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PCRX or AAPL a better investment?
Comparing PCRX and AAPL: Pacira Biosciences Inc has a market cap of $1.03B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PCRX and AAPL?
PCRX (Pacira Biosciences Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PCRX or AAPL?
Based on P/E ratios, AAPL trades at a lower multiple (33.3x vs 149.1x).
Which is growing faster: PCRX or AAPL?
AAPL has higher revenue growth at 0.2% vs 0.1% for PCRX.
Which company is more profitable: PCRX or AAPL?
Pacira Biosciences Inc (PCRX) has higher gross margins at 63.2% compared to 47.3% for AAPL.
Which is the larger company: PCRX or AAPL?
Pacira Biosciences Inc (PCRX) is larger with a market cap of $1.03B compared to N/A for AAPL.
Should I buy PCRX or AAPL in 2026?
Both PCRX and AAPL have investment merit. PCRX trades at $23.86 while AAPL trades at $270.52. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PCRX and AAPL stock?
Key differences: Market Cap ($1.03B vs N/A), P/E Ratio (149.1x vs 33.3x), Revenue Growth (0.1% vs 0.2%), Gross Margin (63.2% vs 47.3%).